Targeting transforming growth factor beta signaling in metastatic osteosarcoma

Osteosarcoma is a rare type of bone cancer, and half of the cases affect children and adolescents younger than 20 years of age. Despite intensive efforts to improve both chemotherapeutics and surgical management, the clinical outcome for metastatic osteosarcoma remains poor. Transforming growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Rongrong, Huang, Gavin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666000/
https://www.ncbi.nlm.nih.gov/pubmed/38021074
http://dx.doi.org/10.1016/j.jbo.2023.100513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666000/
https://www.ncbi.nlm.nih.gov/pubmed/38021074
http://dx.doi.org/10.1016/j.jbo.2023.100513

Ejemplares similares